Guangzhou No.8 People's Hospital

Guangzhou No.8 People's Hospital: A Benchmark Institution for Infectious Disease Control in South China

Guangzhou No.8 People's Hospital (hereinafter referred to as “Guangzhou No.8 Hospital”) stands as one of the most historically established and comprehensively capable Grade III Class A infectious disease specialty hospitals in South China. It serves as a directly affiliated hospital of Guangzhou Medical University and a core unit of the National Clinical Research Center for Infectious Diseases. Guided by the development philosophy of “Comprehensive Infectious Disease Care with Strong General Medical Capabilities,” the hospital enjoys a distinguished reputation in infectious disease prevention and control, treatment of complex and critical illnesses, and public health emergency response. It stands as a vital force in infectious disease prevention and control within the Guangdong-Hong Kong-Macao Greater Bay Area and globally.

I. Hospital Overview

Founded in 1921 as the “Guangzhou Municipal Infectious Diseases Hospital,” Guangzhou Eighth Hospital has evolved over a century from a single-purpose infectious disease facility into a modern comprehensive hospital integrating medical care, teaching, research, and prevention. The hospital currently operates two campuses: the Dongfeng Road Main Campus (Yuexiu District) and the Jiahe Campus (Baiyun District), with over 2,000 open beds and an annual outpatient and emergency volume exceeding 3 million visits. Designated by the National Health Commission as a “Designated Hospital for Severe COVID-19 Treatment” and an “Ebola Hemorrhagic Fever Treatment Center,” and recognized as a “High-Level Hospital Construction Unit” by Guangdong Province, the hospital remains at the forefront of infectious disease prevention and control.

II. Technical Strengths: Focusing on Complex and Critical Cases, Leading Industry Innovation

Guangzhou Eighth Hospital leverages “Precision Diagnosis and Treatment + Innovative Technology” as its core competitive edge, achieving nationally leading and internationally advanced levels in multiple fields:

• Critical Infection Care: Equipped with world-leading ECMO (Extracorporeal Membrane Oxygenation) and Continuous Renal Replacement Therapy (CRRT) systems, the Intensive Care Unit (ICU) achieves over 90% success rates in treating severe hepatitis, opportunistic infections in HIV patients, sepsis, and other critical conditions.

• Viral Hepatitis Treatment: Offers functional cure for chronic hepatitis B (HBsAg seroconversion), precision antiviral therapy based on hepatitis C genotype, and transjugular intrahepatic portosystemic shunt (TIPS) for portal hypertension in cirrhosis. Clinical cure rate for hepatitis B exceeds 35% (above the national average).

• Response to Emerging Infectious Diseases: Equipped with a Biosafety Level 3 (BSL-3) laboratory for rapid pathogen detection and research on COVID-19, monkeypox, and other pathogens. During the 2020 COVID-19 pandemic, the hospital served as Guangzhou's primary critical care hub, pioneering a “combined traditional Chinese and Western medicine + artificial liver support” treatment protocol that significantly reduced severe mortality rates.

III. Leading Specialties: Full-Spectrum Coverage Building “Specialty-Disease” Brands

The hospital maintains comprehensive departments, with nationally renowned infectious disease-related specialties and synergistic development of general departments, forming a “strong specialties, excellent general care” structure:

• National Key Clinical Specialties: Infectious Diseases Department (ranked among China's top five), Liver Disease Center (South China's leading liver disease diagnosis and treatment center).

• Provincial Key Specialties: AIDS Department (host institution of Guangdong Provincial AIDS Diagnosis and Treatment Quality Control Center), Critical Care Medicine, Traditional Chinese Medicine (distinguished for integrated TCM-Western medicine treatment of infectious diseases).

• Distinctive Specialties:

• Interventional Hepatology: Performs minimally invasive therapies including radiofrequency ablation for hepatocellular carcinoma and transarterial chemoembolization (TACE), with annual procedures exceeding 2,000.

• Infectious Disease Prevention and Control Center: Assumes public health responsibilities, including infectious disease surveillance and vaccine strategy formulation for Guangzhou City.

• Obstetrics and Gynecology: Specializes in mother-to-child transmission prevention for infectious diseases like hepatitis B and syphilis, achieving over 99% prevention success rates.

IV. Medical Equipment: Cutting-Edge Technology Enabling Precision Diagnosis and Treatment

The hospital is equipped with world-leading infectious disease diagnostic and treatment devices to support clinical and research needs:

• Diagnostic Equipment: Roche Cobas 8800 fully automated nucleic acid analysis system (achieving viral load detection accuracy down to 20 IU/mL), next-generation sequencing (NGS) metagenomic pathogen detection platform (enabling rapid identification of rare pathogens).

• Therapeutic Equipment: Fresenius Medical Care (Germany) Artificial Liver Support System (DPMAS), Asahi Kasei (Japan) ECMO (Extracorporeal Life Support), Medtronic (USA) Insulin Pump (for diabetes with infection management).

• Research Equipment: Flow Cytometer (immune function analysis), Laser Confocal Microscope (viral invasion mechanism research), etc., supporting clinical trials and translational research for new drugs.

V. International Patient Services: Comprehensive Care Breaking Language and Cultural Barriers

As a key gateway for international healthcare in South China, Guangzhou Eighth People's Hospital offers foreign patients “one-stop” services:

• Multilingual Support: Professional translation teams fluent in English, Japanese, Korean, Arabic, etc., provide bilingual guidance and medical record translation at the international outpatient clinic.

• Direct Billing with International Insurers: Partners with global insurers like MSH (Mansfield Health Solutions) and Cigna for seamless claims processing.

• Personalized Care: Dedicated International Medical Department offers VIP rooms (with private bathrooms and guest areas), customized diets (halal, vegetarian, etc.), and religious accommodation (e.g., prayer rooms).

• Convenient Healthcare Services: Assistance with visa extensions, transportation arrangements (via international travel agencies), and remote consultations (connecting to top global hospitals).

VI. Medical Rankings: Domestic Leadership, Global Recognition

• China Medical Rankings:

• Infectious Diseases Department: Ranked 4th nationally and 1st in South China in Fudan University's 2023 China Hospital Rankings. Hepatology ranked 2nd in South China.

• International Influence: As a WHO Collaborating Center (Tropical Disease Research), it contributed to developing the Global Hepatitis B Prevention and Control Guidelines and the African Consensus on Antiretroviral Therapy for HIV/AIDS; established long-term collaborations with institutions including Johns Hopkins University (USA) and University College London (UK), conducting over 30 global multicenter clinical trials.

VII. International Patient Testimonials: A Treatment Experience Combining Expertise and Compassion

• “As a hepatitis B patient from Nigeria, I received antiviral treatment here. After three months, my viral load dropped from 10⁸ to below detectable levels. The doctors also taught me how to manage my condition.” — Mohammed (32, Nigeria)

• “During the pandemic, my family member spent 28 days in the ICU here. The medical team used ECMO and artificial liver support to pull him back from the brink of death. They were not only highly professional but also used simple English to calm our emotions.” — —John (45, USA)

• “As a Korean working in Guangzhou, I chose this hospital for hepatitis B mother-to-child transmission prevention. The entire process went smoothly, and my baby tested positive for antibodies after birth. Thank you for the hospital's professionalism!” —Park Jiyeon (30, South Korea)

VIII. Contact Information, Address & Transportation Routes

• Address:

• Main Hospital: 627 Dongfeng East Road, Yuexiu District, Guangzhou (near Metro Quzhuang Station);

• Jiahe Branch: 8 Huaying Road, Jiahe Street, Baiyun District, Guangzhou (near Metro Jiahe Wanggang Station).

• Contact Information:

• Main Switchboard: 020-83838688 (Main Hospital), 020-36554252 (Jiahe Branch);

• International Medical Department: 020-83838688 ext. 8100 (English/Japanese services);

• WeChat Official Account: “Guangzhou No.8 People's Hospital”.

• Transportation Routes:

• Subway: For Main Campus, take Line 5 to “Quzhuang Station” Exit A; for Jiahe Campus, take Line 2/3 to “Jiahe Wanggang Station” Exit B.

• Bus: Near Main Campus is “Zhi Xin Middle School Station” (Routes 16, 18, 22, etc.); Jiahe Campus: “Municipal Transportation Control Center Station” (Routes 259, 509, 510, etc.).

• Driving: Main Campus features an underground parking garage (fee applies); Jiahe Campus offers 200 parking spaces. Navigate to “Guangzhou No.8 People's Hospital Jiahe Campus”.

Conclusion

From its origins as an infectious disease hospital in 1921 to its current status as a “dual-campus, high-level medical institution,” Guangzhou No.8 People's Hospital has steadfastly upheld its mission of “safeguarding lives” through relentless dedication to infectious disease prevention and control. The trust of local patients and recognition from international patients alike affirm its pivotal role in South China's—and indeed the global—landscape of infectious disease healthcare. Looking ahead, as the “Healthy China” initiative advances, Guangzhou No.8 People's Hospital will continue leveraging its technical strengths to contribute “Guangzhou wisdom” to global public health endeavors.

Document dated 2025-09-15 18:21 Modify